VALFIX has created a revolutionary mitral valve repair system. The technology was designed to fully convert open heart valve surgery into a transcatheter procedure. Severe functional mitral regurgitation (FMR) affects millions of patients. Due to high surgical risks, only a small percentage of patients undergo open-heart valve surgery. Nearly half of the remaining patients, who are treated with medication only, will die within two years. VALFIX system offers a solution to the millions of patients currently without viable treatment. VALFIX’s innovative and game-changing system allows cardiologists to perform transcatheter mitral valve repair procedures to alleviate heart failure symptoms, improve quality of life, and save lives.